AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,623,843 | -12.6% | 267,630 | 0.0% | 1.46% | +3.0% |
| Q2 2023 | $7,579,282 | +23.3% | 267,630 | 0.0% | 1.42% | +18.4% |
| Q1 2023 | $6,147,461 | -18.2% | 267,630 | 0.0% | 1.20% | -31.0% |
| Q4 2022 | $7,515,050 | -19.4% | 267,630 | -18.8% | 1.73% | -19.0% |
| Q3 2022 | $9,324,000 | -27.0% | 329,713 | -42.8% | 2.14% | -28.2% |
| Q2 2022 | $12,779,000 | +1.8% | 576,413 | +33.6% | 2.98% | -3.7% |
| Q1 2022 | $12,558,000 | -11.4% | 431,413 | 0.0% | 3.09% | -10.4% |
| Q4 2021 | $14,181,000 | +30.5% | 431,413 | +83.2% | 3.46% | +0.2% |
| Q3 2021 | $10,869,000 | -16.3% | 235,513 | 0.0% | 3.45% | -22.6% |
| Q2 2021 | $12,979,000 | -29.1% | 235,513 | -33.6% | 4.45% | -38.0% |
| Q1 2021 | $18,314,000 | +506.4% | 354,650 | +408.8% | 7.19% | +272.0% |
| Q4 2020 | $3,020,000 | – | 69,700 | – | 1.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |